Incyte

Incyte is a biopharmaceutical company focused on discovering, developing, and commercializing proprietary therapeutics. They generate revenue primarily through the sale of their flagship drug, Jakafi, which treats myelofibrosis and polycythemia vera, along with licensing agreements and collaborations. Founded in 1991 and headquartered in Wilmington, Delaware, Incyte has a rich history of innovation in oncology and inflammation. Notably, their robust pipeline includes numerous clinical-stage compounds targeting various cancers and autoimmune diseases, underscoring their commitment to addressing unmet medical needs.

Recent Posts by Incyte

1-20 of 548